WISE Srl, the medical device company developing nextgeneration implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing, announced the closing of a EUR 15 million Series C financing round.
New investors, led by CDP Venture Capital SGR, and including Indaco Ventures I Fund and EUREKA! Venture SGR, joined existing investors participating in this round – Principia SGR, New Frontier, Atlante Seed and Atlante Ventures (funds managed by Indaco Venture Partners SGR), High Tech Gründerfonds and F3F.
Read more here.